Glutaminase 2 (GLS2), targeted by miR-103a-3p, can be downregulated to inhibit GC cell proliferation and promote ferroptosis (Hu et al., 2018; Wu et al., 2020). The gene discussed is GLS2; the disease is gastric cancer.